国际标准期刊号: 2161-1165

Epidemiology: Open Access

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • 哥白尼索引
  • 谷歌学术
  • 夏尔巴·罗密欧
  • Genamics 期刊搜索
  • 安全点亮
  • 访问全球在线农业研究 (AGORA)
  • 国际农业与生物科学中心 (CABI)
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-世界猫
  • CABI 全文
  • 出租车直达
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 欧洲酒吧
  • ICMJE
分享此页面

抽象的

Survival Rates of HIV Patients on Antiretroviral Therapy in the Kumba Health District: A Six-Year Retrospective Cohort Study from 2008 To 2013

Achangwa Chiara, Fomboh Richard, Abel Wilson Wickelema

Anti-Retroviral Therapy (ART) has clearly been shown to be effective in reducing mortality amongst those who remain on treatment and adhere to therapy. Recently, in developing countries where the burden of HIV/AIDS is high, ART has become more available. The outcome of patients with HIV/AIDS has improved dramatically since 1996 for those who have access to the appropriate treatment. This study was carried out to determine the survival rates of HIV/AIDS patients on antiretroviral therapy in the Kumba Health District. A six –year retrospective cohort study involving collection of point of care data from 2008 to 2013 was carried out to assess the survival rate of HIV patients on treatment in the HIV/AIDS treatment centers in the Kumba Health District. The study was carried out in two phases. Phase one assessed the quality of data and phase two involved collection of data from the ARV registers. It was found that the Kumba Health District place a total of 5421 (1524 males, 3897 females) on ARV treatment. An overall data quality score of 72.4% was observed. The overall loss to follow up rate was 18.19%, males having higher loss to follow up rate (27.62%) compared to females (13.99%). Females had a higher five-year survival rate (76.64%) compared to males (65.6%). The five year survival rate was highest in the age-group 31-45 years (77.0%) and least in the age group 0-15 years (47.1%). It was observed that 73.23% of the patients survived five years after initiation into treatment. Earlier initiation on ART through expanded testing and counselling should be encouraged in HIV-infected patients in order to increase the survival rate.